UNE APPLICATION DES METHODES STATISTIQUES A L'ETUDE DES BLOCS ERRATIQUES DE LA FENNOSCANDIE ASSOCIES AUX DEPOTS GLACIAIRES DE LA PARTIE NORD-EST DE LA POLOGNE.NUNBERG J.1971; STUD. GEOL. POLON.; POL; 1971, VOL. 37, P. 1 A 103Miscellaneous

SEDYMENTACJA UTWOROW ZASTOISKOWYCH W MARGINALNEJ STREFIC ZLODOWACENIA SRODKOWOPOLSKIEGO KOLO STARZECHOWIC (ZACHODNIE OBRZEZENIE GOR SWIETOKRZYSKICH) = DEPOSITION OF ICE-DAM LACUSTRINE DEPOSITS IN A MARGINAL ZONE OF MIDDLE-POLISH GLACIATION NEARBY SATRZECHOWICE (WESTERN MARGIN OF THE HOLY CROSS MTS) = SEDIMENTATION DES DEPOTS LACUSTRES DANS LA ZONE MARGINALE DE LA GLACIATION POLONAISE CENTRALE PRES DE STARZECHOWICE (BORDURE OCCIDENTALE DES MONTS SAINTE CROIX)LASKOWSKA WYSOCZANSKA W; NUNBERG J.1982; BIULETYN GEOLOGICZNY; ISSN 0067-9003; POL; DA. 1982; VOL. 26; PP. 253-267; H.T. 2; ABS. ENG; BIBL. 2 REF.Article

CONSTRUCTION OF BACTERIAL PLASMIDS THAT CONTAIN THE NUCLEOTIDE SEQUENCE FOR BOVINE CORTICOTROPIN-BETA -LIPOTROPIN PRECURSORNAKANISHI S; INOUE A; KITA T et al.1978; PROC. NATION. ACAD. SCI. U.S.A.; USA; DA. 1978; VOL. 75; NO 12; PP. 6021-6025; BIBL. 43 REF.Article

Recombinant feline herpes viruses expressing feline leukemia virus envelope and gag proteinsCOLE, G. E; STACY-PHILIPPS, S; NUNBERG, J. H et al.Journal of virology. 1990, Vol 64, Num 10, pp 4930-4938, issn 0022-538X, 9 p.Article

Feline leukemia virus envelope protein expression encoded by a recombinant vaccinia virus: apparent lack of immunogenicity in vaccinated animalsGILBERT, J. H; PEDERSEN, N. C; NUNBERG, J. H et al.Virus research. 1987, Vol 7, Num 1, pp 49-67, issn 0168-1702Article

Method to map antigenic determinants recognized by monoclonal antibodies: localization of a determinant of virus neutralization on the feline leukemia virus envelope protein gp70 = Méthode pour situer les déterminants antigéniques reconnus par les anticorps monoclonaux: localisation d'un déterminant de la neutralisation du virus sur la protéine gp70 de l'enveloppe du virus de la leucémie félineNUNBERG, J. H; RODGERS, G; GILBERT, J. H et al.Proceedings of the National Academy of Sciences of the United States of America. Biological sciences. 1984, Vol 81, Num 12, pp 3675-3679, issn 0273-1134Article

Turning a corner on HIV neutralization?NUNBERG, J. H; FOLLIS, K. E; TRAHEY, M et al.Microbes and infection. 2000, Vol 2, Num 2, pp 213-221, issn 1286-4579Article

Interleukin 2 acts as an adjuvant to increase the potency of inactivated rabies virus vaccineNUNBERG, J. H; DOYLE, M. V; YORK, S. M et al.Proceedings of the National Academy of Sciences of the United States of America. 1989, Vol 86, Num 11, pp 4240-4243, issn 0027-8424Article

Identification of the thymidine kinase gene of feline herpesvirus: use of degenerate oligonucleotides in the polymerase chain reaction to isolate herpesvirus gene homologsNUNBERG, J. H; WRIGHT, D. K; COLE, G. E et al.Journal of virology. 1989, Vol 63, Num 8, pp 3240-3249, issn 0022-538XArticle

Fusion-competent vaccines : Broad neutralization of primary isolates of HIVLACASSE, R. A; FOLLIS, K. E; TRAHEY, M et al.Science (Washington, D.C.). 1999, Vol 283, Num 5400, pp 357-362, issn 0036-8075Article

Release of human serum albumin from poly(lactide-co-glycolide) microspheresHORA, M. S; RANA, R. K; NUNBERG, J. H et al.Pharmaceutical research. 1990, Vol 7, Num 11, pp 1190-1194, issn 0724-8741, 5 p.Article

Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitorsNUNBERG, J. H; SCHLEIF, W. A; BOOTS, E. J et al.Journal of virology. 1991, Vol 65, Num 9, pp 4887-4892, issn 0022-538XArticle

Immunogenicity and HIV-1 virus neutralization of MN recombinant glycoprotein 120/HIV-1 QS21 vaccine in baboonsPOWELL, M. F; CLELAND, J. L; EASTMAN, D. J et al.AIDS research and human retroviruses. 1994, Vol 10, pp S105-S108, issn 0889-2229, SUP2Conference Paper

L-696,229 specifically inhibits human immunodeficiency virus type 1 reverse transcriptase and possesses antiviral activity in vitroGOLDMAN, M. E; O'BRIEN, J. A; RUFFING, T. L et al.Antimicrobial agents and chemotherapy. 1992, Vol 36, Num 5, pp 1019-1023, issn 0066-4804Article

Pyridinone derivatives : specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activityGOLDMAN, M. E; NUNBERG, J. H; HUPE, D. J et al.Proceedings of the National Academy of Sciences of the United States of America. 1991, Vol 88, Num 15, pp 6863-6867, issn 0027-8424Article

Synthesis and antiviral activity of a series of HIV-1 protease inhibitors with functionality tethered to the P₁ or P₁' phenyl substituents : X-ray crystal structure assisted designTHOMPSON, W. J; FITZGERALD, P. M. D; SCHWERING, J. E et al.Journal of medicinal chemistry (Print). 1992, Vol 35, Num 10, pp 1685-1701, issn 0022-2623Article

Synthesis and evaluation of 2-pyridinone derivatives as HIV-1-specific reverse transcriptase inhibitors. 2: Analogues of 3-aminopyridin-21H=-oneSAARI, W. S; WAI, J. S; O'BRIEN, J. A et al.Journal of medicinal chemistry (Print). 1992, Vol 35, Num 21, pp 3792-3802, issn 0022-2623Article

Synthesis and evaluation of 2-pyridinone derivatives as HIV-1-specific reverse transcriptase inhibitors. IV: 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one and analoguesHOFFMAN, J. M; SMITH, A. M; OLSON, B. D et al.Journal of medicinal chemistry (Print). 1993, Vol 36, Num 8, pp 953-966, issn 0022-2623Article